Home›Research›Compare›Cagrilintide vs Retatrutide
Peptide Comparison
Cagrilintide vs Retatrutide
Both are Fat Loss peptides.
Cagrilintide
AM833
Half-life: ~7 days
13 providers listed
Retatrutide
LY3437943
Half-life: ~6 days
73 providers listed
Quick Verdict
Cagrilintide
Risk
Half-life
~7 days
Retatrutide
Risk
Half-life
~6 days
Side-by-Side Comparison
About Cagrilintide
Long-acting amylin analogue; acts on amylin/calcitonin receptors to prolong satiety; synergistic with semaglutide in CagriSema combination
A once-weekly long-acting amylin analogue in late-stage development. Showing impressive weight loss (~15%) in trials, especially when combined with semaglutide (CagriSema).
Research Areas
About Retatrutide
Triple GIP/GLP-1/glucagon receptor agonist; targets three pathways for synergistic fat reduction
A triple agonist peptide in clinical development showing exceptional weight loss results (up to 24% body weight). Targets GIP, GLP-1, and glucagon receptors simultaneously.
Research Areas
Find Providers
Where to source these peptides
Providers offering
Cagrilintide
13 listed
Browse directory →
Providers offering
Retatrutide
73 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More fat loss Comparisons
Browse all peptides →Educational research tools — not medical advice.